THE 2-MINUTE RULE FOR API IN PHARMACEUTICAL MANUFACTURING

“The present situation has exposed some structural weaknesses while in the EU’s medicines offer chain as well as a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides reported. She advised that offer chain problems be dealt with in an EU pharmaceutical system predicted to get launched by the end with the c